Header cover image

U.S. Pharmaceuticals & Biotech Buy the Dip

UPDATED Nov 28, 2023

Companies which may present a buying opportunity after a dip in share price.

84 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
MLABMesa LaboratoriesUS$87.63-1.0%-46.9%US$466.1mUS$115.00PS2.2xE110.0%0.7%
MDXGMiMedx GroupUS$7.899.4%155.3%US$921.6mUS$11.65PS3xE49.2%n/a
ILMNIlluminaUS$96.540.6%-53.7%US$15.0bUS$153.35PS3.4xE80.3%n/a
RCELAVITA MedicalUS$10.775.9%65.2%US$277.3mUS$24.52PS6.1xE47.8%n/a
OGNOrganonUS$11.302.4%-54.7%US$2.9bUS$20.33PE4.9xE24.5%9.9%
ELANElanco Animal HealthUS$11.991.8%-2.1%US$5.9bUS$13.33PS1.4xE96.5%n/a
ASRTAssertio HoldingsUS$1.15-3.4%-60.9%US$112.7mUS$3.88PB0.6xE105.2%n/a
AMRNAmarinUS$0.74-3.2%-34.7%US$317.2mUS$2.05PB0.5xE42.4%n/a
BIOBio-Rad LaboratoriesUS$304.40-0.6%-23.8%US$8.9bUS$444.60PS3.3xE57.6%n/a
AYTUAytu BioPharmaUS$2.38-3.1%-40.6%US$14.0mUS$5.00PB0.4xE95.7%n/a
MCRBSeres TherapeuticsUS$1.138.1%-83.0%US$149.9mUS$8.54PS1.1xE35.9%n/a
CBUSCibusUS$13.458.0%79.0%US$254.6mUS$22.00PS297.1xE18.6%n/a
ARQTArcutis BiotherapeuticsUS$2.047.9%-88.0%US$185.0mUS$11.17PS3.9xE42.6%n/a
TBIOTelesis BioUS$0.4034.5%-71.2%US$10.3mUS$4.00PB0.7xE60.9%n/a
IMABI-MabUS$1.552.0%-56.1%US$127.0mUS$25.68PB0.4xE26.1%n/a
BMYBristol-Myers SquibbUS$48.920.9%-38.1%US$99.7bUS$64.13PE12xE11.4%4.7%
IFRXInflaRxUS$1.37-6.2%-47.1%US$82.4mUS$10.13PS1207.7xE50.0%n/a
RZLTRezoluteUS$0.76-5.4%-53.6%US$30.7mUS$7.60PB0.3xE34.7%n/a
ADCTADC TherapeuticsUS$0.730.8%-78.4%US$58.4mUS$8.00PE-0.3xE16.1%n/a
TKNOAlpha TeknovaUS$2.07-4.6%-55.4%US$83.7mUS$4.83PS2.3xE31.8%n/a
CARMCarisma TherapeuticsUS$2.37-3.1%n/aUS$98.1mUS$10.00PS6.6xE9.6%n/a
RCKTRocket PharmaceuticalsUS$22.412.5%23.9%US$2.1bUS$51.75PB3.7xE56.9%n/a
RVNCRevance TherapeuticsUS$7.06-2.4%-67.7%US$605.9mUS$26.92PS2.9xE58.0%n/a
AGENAgenusUS$0.703.4%-73.2%US$251.9mUS$6.67PS2.7xE8.6%n/a
Page 1 of 4